Robert Schoenleber
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Immunology top 10%
- Immune Response and Inflammation
Papers in
-
- Receptor Mechanisms and Signaling 7
- Melanoma and MAPK Pathways 2
-
- Synthesis and biological activity 2
- Co-authors
- Jennifer L. Best (1 shared paper)Sarah A. Moore (1 shared paper)Jacqueline W. Pierce (1 shared paper)Gary Jesmok (1 shared paper)Tucker Collins (1 shared paper)Mary E. Gerritsen (1 shared paper)Michael P. DeNinno (6 shared papers)Donald R. Britton (6 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of the American Chemical Society (2 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Robert Schoenleber
18 papers receiving 1.5k citations
Robert Schoenleber's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 370
- Immunology 383
- Cellular and Molecular Neuroscience 236
- Molecular Biology 775
- Toxicology 30
Countries citing papers authored by Robert Schoenleber
This map shows the geographic impact of Robert Schoenleber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schoenleber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schoenleber more than expected).
Fields of papers citing papers by Robert Schoenleber
This network shows the impact of papers produced by Robert Schoenleber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schoenleber. The network helps show where Robert Schoenleber may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Schoenleber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo Hit paper breakdown → | 1997 | 924 |
| 2 | 1992 | 129 | |
| 3 | 1991 | 66 | |
| 4 | 1991 | 55 | |
| 5 | 2000 | 47 | |
| 6 | 2007 | 43 | |
| 7 | 1990 | 40 | |
| 8 | 2000 | 34 | |
| 9 | 1983 | 34 | |
| 10 | 2003 | 31 | |
| 11 | 1984 | 29 | |
| 12 | 1986 | 26 | |
| 13 | 1984 | 25 | |
| 14 | 1984 | 21 | |
| 15 | 1991 | 13 | |
| 16 | 1992 | 10 | |
| 17 | 1990 | 8 | |
| 18 | 1989 | 1 |
About Robert Schoenleber
Robert Schoenleber is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Rheumatology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (7 papers), Computational Drug Discovery Methods (2 papers), Melanoma and MAPK Pathways (2 papers), Synthesis and biological activity (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Inflammatory mediators and NSAID effects (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Glycogen Storage Diseases and Myoclonus (2 papers). The work is most often cited by research in Cancer Research (370 citations), Immunology (383 citations), Cellular and Molecular Neuroscience (236 citations), Molecular Biology (775 citations) and Toxicology (30 citations). Robert Schoenleber has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jennifer L. Best, Sarah A. Moore, Jacqueline W. Pierce, Gary Jesmok, Tucker Collins, Mary E. Gerritsen, Michael P. DeNinno, Donald R. Britton, Henry Rapoport and Robert G. MacKenzie. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.